SOLUTION FOR INHALATION OF PHARMACEUTICAL COMPOSITION "GLUTOVENT" AND METHOD FOR TREATMENT WITH ITS USING

FIELD: medicine, pharmacy. SUBSTANCE: solution for inhalation contains the following components, wt.-%: glutoxime that represents bis-(gamma-L-glutamyl)-L-cysteinyl-bis-glycine disodium salt, 1.90-2.10; theophylline, 0.45-0.55; riboxin, 0.90-1.10; dimexide, 2.80-3.20; sodium chloride, 0.75-0.95; wat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZAJTSEVA M.A, KOZHEMJAKIN L.A
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, pharmacy. SUBSTANCE: solution for inhalation contains the following components, wt.-%: glutoxime that represents bis-(gamma-L-glutamyl)-L-cysteinyl-bis-glycine disodium salt, 1.90-2.10; theophylline, 0.45-0.55; riboxin, 0.90-1.10; dimexide, 2.80-3.20; sodium chloride, 0.75-0.95; water for injection, the balance, up to 10 g. Glutoxime-base solution provides dispersion of microparticles in the range 5-10 mcm in inhalation through nebulizer with compress feeding compressed air (oxygen). Agent shows cytoprotective, immunomodulating, broncholytic, desensitizing, antibacterial and anti-inflammatory activity. Invention proposes also method for prophylaxis and treatment of chronic diseases of lower respiratory ways of viral and bacterial genesis by administration of indicated solution to patient. EFFECT: valuable medicinal properties of solution. 9 cl, 3 tbl, 5 ex